LEVITRA (KAISER FOUNDATION HOSPITALS)
Welcome to the PulseAid listing for the LEVITRA drug offered from KAISER FOUNDATION HOSPITALS. This Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | KAISER FOUNDATION HOSPITALS |
| NON-PROPRIETARY NAME: | VARDENAFIL HYDROCHLORIDE |
| SUBSTANCE NAME: | VARDENAFIL HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-10-28 |
| END MARKETING DATE: | 0000-00-00 |
LEVITRA HUMAN PRESCRIPTION DRUG Details:
| Item Description | LEVITRA from KAISER FOUNDATION HOSPITALS |
| LABELER NAME: | KAISER FOUNDATION HOSPITALS |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/1) |
| START MARKETING DATE: | 2011-10-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0179-0102_cb3bc5aa-99ed-4705-951a-a2220ef78016 |
| PRODUCT NDC: | 0179-0102 |
| APPLICATION NUMBER: | NDA021400 |
Other VARDENAFIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
